Home > News > Content

How Can Domestic Pharmaceutical Machinery Companies Shorten The Gap With Foreign Countries?

May 07, 2019

How can domestic pharmaceutical machinery companies shorten the gap with foreign countries?


It is understood that in recent years, China's manufacturing enterprises have continuously enhanced their innovation capabilities, but there is still a relatively large gap compared with the world's manufacturing powers.

Specifically, independent innovation, especially the original innovation ability is not strong, the transformation efficiency of scientific and technological achievements is not high, the industry common technology research and development is slow, and the proportion of basic research expenditures to research and development expenditure is far lower than the average level of developed countries.

As an important part of China's manufacturing industry, the pharmaceutical machinery and equipment industry is also facing the challenge of innovation.


According to industry insiders, from the current situation of China's pharmaceutical equipment market, despite years of wind and rain, domestic pharmaceutical equipment has made great progress, and many pharmaceutical companies have even crossed the country. However, on the whole, pharmaceutical equipment enterprises are characterized by small, scattered and chaotic, product repetition rate is low, imitation, and even counterfeit phenomenon frequently occur. This is not conducive to the development of the entire industry for the industry, innovation has become the key to the development of the entire pharmaceutical industry and even each pharmaceutical company.

Xin Guobin, deputy minister of the Ministry of Industry and Information Technology, once said that it is necessary to firmly grasp the "burning" of innovation, and focus on improving the innovation capability of the manufacturing industry, focusing on key core technology research and transformation of results, and accelerating industrial transformation and upgrading.


In view of the current development of the pharmaceutical machinery and equipment industry, China's pharmaceutical machinery industry is also paying close attention to the relevant national favorable policies for innovation and development. Starting from the positioning of the company itself, under the premise of grasping the market development trend, from the aspects of technology, research and development, market, etc. Explore innovative models and strive to accelerate the transformation and upgrading of enterprises.

In terms of technological innovation, taking freeze-drying technology as an example, in view of the defects that the current freeze dryer has requirements for environmental temperature and humidity, some companies are using vacuum freeze-drying technology to develop new products. This is an excellent and improved drying method. When the dried product is under sealed conditions, it can be stored for a long time without additives at room temperature, and is especially suitable for food, health care products and pharmaceutical industries.

In terms of market breakthroughs, packaging machinery is an example. At present, China's packaging machinery enterprises are seeking to obtain favorable packaging for the pharmaceutical market from packaging materials, equipment and sales. Industry insiders have also said: "We are entering a new world of packaging for mechatronics, laser scanning, radio frequency emission, nanotechnology and system simplification."

In terms of R&D innovation, some companies have developed distinctive medical equipment by introducing innovative talents. Compared with the same type of equipment, it has increased the degree of automation, high production efficiency, user-friendly design, and low cost of employment, which is beneficial to enterprises to win more benefits.

At the same time, in response to domestic imitation, many pharmaceutical companies in China have begun to pay attention to property rights issues, actively apply for patents, maintain innovation results, and actively respond to fierce market competition and challenges with greater advantages.

In general, technology is the core guarantee for enterprise innovation transformation, talent is an important force to ensure innovation, and quality is also the guarantee of product fate. In the process of development, pharmaceutical companies are only brave in innovation, and strive to improve product quality, in order to better serve our customers, win the attention in the market, and promote the more stable development of China's pharmaceutical industry.